Amgen Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Amgen Inc. reported total assets of $90.59B and shareholders' equity of $8.66B. That works out to a current ratio of 1.14 (current assets ÷ current liabilities), long-term debt of 5.78× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $77.63B | $79.95B | $66.42B | $59.71B | $62.95B | $61.16B | $65.12B | $97.15B | $91.84B | $90.59B |
| Current assets | $46.01B | $49.48B | $37.62B | $18.44B | $21.14B | $19.39B | $22.19B | $30.33B | $29.03B | $29.06B |
| Cash & equivalents | $3.24B | $3.80B | $6.95B | $6.04B | $6.27B | $7.99B | $7.63B | $10.94B | $11.97B | $9.13B |
| Current liabilities | $11.20B | $9.02B | $13.49B | $12.84B | $11.65B | $12.18B | $15.69B | $18.39B | $23.10B | $25.49B |
| Long-term debt | $30.19B | $34.19B | $29.51B | $26.95B | $32.90B | $33.22B | $37.35B | $63.17B | $56.55B | $50.01B |
| Shareholders' equity | $29.88B | $25.24B | $12.50B | $9.67B | $9.41B | $6.70B | $3.66B | $6.23B | $5.88B | $8.66B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 318154 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.